Daily non-political popular news in brief.

Genetic differences may help explain response to multiple sclerosis treatment

By comparing the DNA of patients with multiple sclerosis whose symptoms are reduced by interferon beta therapy to the DNA of those who continue to experience relapses, researchers may have identified important genetic differences between the two, according to an article posted online today that will appear in the March 2008 print issue of Archives of Neurology, one of the JAMA/Archives journals. These differences could eventually be used to help predict which treatments will help which patients.

Read more »

Keywords: genetic, differences, explain, response, multiple, sclerosis, treatment, difference, sclerosi

« Previous | Next »

Similar news on "Genetic differences may help explain response to multiple sclerosis treatment":

1. Israeli scientists identify: Genes that affect responses of multiple sclerosis patients to copaxone
   10-10-2007 · EurekAlert!
   Getting the drug dosage correct can be a tricky exercise in trial and error in a disease like multiple sclerosis. Scientists from the Weizmann Institute and the Technion have identified two genes that affect a patient's response to the drug Copaxone, a finding which may help take the some of the guesswork out of treatment.
   Similar news · Read more »
   
2. Novel MS drug shows promise in 2 lethal leukemias
   08-28-2007 · EurekAlert!
   A new study suggests that an experimental drug being tested for the treatment of multiple sclerosis and to prevent organ rejection might also help people with certain deadly forms of chronic and acute leukemia. The laboratory and animal study focused on the drug, called fingolimod. Researchers said it might help patients with advanced chronic myelogenous leukemia or acute lymphocytic leukemia, and whose cancer cells show a particular genetic change called the Philadelphia chromosome.
   Similar news · Read more »
   
3. Individual differences in a clock gene predict decline of performance during sleep deprivation
   03-08-2007 · EurekAlert!
   People are known to differ markedly in their response to sleep deprivation, but the biological underpinnings of these differences have remained difficult to identify. Researchers have now found that a genetic difference in a so-called clock gene, PERIOD3, makes some people particularly sensitive to the effects of sleep deprivation.
   Similar news · Read more »
   
4. New clue why MS affects African-Americans differently than Caucasians
   07-02-2007 · EurekAlert!
   Differences in immune systems have been found in African-Americans with multiple sclerosis (MS) compared to Caucasians, possibly offering a clue why African-Americans experience more disability with MS than Caucasians, according to a study published in the July 3, 2007, issue of Neurology, the medical journal of the American Academy of Neurology.
   Similar news · Read more »
   
5. First new multiple sclerosis gene found in 30 years
   07-29-2007 · EurekAlert!
   A newly identified gene may hold the promise of guiding future research into therapies for multiple sclerosis in what its discoverers say is the first major genetic advance in 30 years for understanding this nervous system disease.
   Similar news · Read more »
   
6. MIT: Why men are more prone to liver cancer
   01-15-2008 · EurekAlert!
   A fundamental difference in the way males and females respond to chronic liver disease at the genetic level helps explain why men are more prone to liver cancer, according to MIT researchers.
   Similar news · Read more »
   
7. Penn researchers find treatment for MS also reduces vision loss in MS patients
   04-16-2007 · EurekAlert!
   According to a study that appears in the April 17 issue of Neurology, researchers at the University of Pennsylvania School of Medicine have found that natalizumab (TYSABRI) -- a drug that slows disability and reduces relapse rates in patients with multiple sclerosis (MS) -- also reduces vision loss in patients with relapsing MS. Vision loss is one of the most common and disabling symptoms of MS.
   Similar news · Read more »
   
8. Glucosamine-like supplement inhibits multiple sclerosis, type 1 diabetes
   05-14-2007 · EurekAlert!
   A glucosamine-like dietary supplement has been found to suppress the damaging autoimmune response seen in multiple sclerosis and type-1 diabetes mellitus, according to University of California, Irvine health sciences researchers.
   Similar news · Read more »
   
9. Genes key to high liver cancer rates in men
   01-15-2008 · Massachusetts Institute of Technology (MIT)
   A fundamental difference in the way males and females respond to chronic liver disease at the genetic level helps explain why men are more prone to liver cancer, according to MIT researchers, who conducted the first genome-wide study on the subject.
   Similar news · Read more »
   
10. Extracellular protein sensitizes ovarian cancer cells to chemotherapy
    12-10-2007 · EurekAlert!
    Scientists have uncovered critical new details about the mechanisms that modulate the response of ovarian cancer cells to chemotherapy. The research, published by Cell Press in the December issue of Cancer Cell, helps to explain why many patients develop resistance to the taxane class of drugs and may lead to improved treatment of ovarian cancer.
    Similar news · Read more »